A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about the following questions in the patients
receiving maintenance hemodialysis with elevated blood phosphorus:
- How much effect AP-306 has assessed by blood phosphorus lowering;
- How safe and tolerable AP-306 is.
Participants will receive either following treatments:
- AP-306, and
- Sevelamer carbonate.